Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 13, 2025 08:00 ET | Source: CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.

Brian Cuban to Represent CBIH in DEA Hearings on Marijuana Reclassification

CBIH is proud to announce that Brian Cuban, Esq. has officially joined the Reclassification Team.
January 06, 2025 08:00 ET | Source: CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.

Cannabis Bioscience International Holdings (CBIH) Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products

Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is thrilled to announce a groundbreaking partnership with Stephen Gould
December 16, 2024 08:00 ET | Source: CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.

CBIH Files Petition to Include Alexis Bortell as Witness in DEA Rescheduling Hearing

CBIH has formally filed a petition to have Ms. Alexis Bortell serve as a witness in the upcoming DEA hearing on marijuana rescheduling.
December 09, 2024 08:00 ET | Source: CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.

A Letter from the Desk of CBIH

Cannabis Bioscience International Holdings CEO Dante Picazo Addresses Cannabis Reclassification and DEA Hearings
December 02, 2024 08:00 ET | Source: CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.

CBIH Advocates for Cannabis Policy Reform at DEA Reclassification Hearing

Cannabis Bioscience International Holdings (OTCMKTS: CBIH) proudly announces its active participation in today’s DEA meaningful hearing
November 25, 2024 08:00 ET | Source: CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.

CBIH Unveils the Future of Wellness with Revolutionary Anti-Aging Chip

our Research and Development team is redefining the possibilities of cannabinoid-based biotechnologies and at the heart of these innovations lies the Rejuv
November 18, 2024 08:00 ET | Source: CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.

CBIH Strengthens Clinical Research Team in Preparation for Launch of Next-Generation Cannabinoid Solutions

Cannabis Bioscience International Holdings (OTCMKTS: CBIH) continues to invest in top-tier talent as it prepares to launch its specialized pharmaceutical a
November 12, 2024 08:00 ET | Source: CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.

Cannabis Bioscience International Holdings Selected to Participate in DEA Hearing on Cannabis Rescheduling Docket No. 1362 and Hearing Docket No. 24-44

Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is honored to announce it was selected from a competitive field of numerous companies as one of
July 15, 2024 08:00 ET | Source: CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.

CBIH Pursues Regulatory Compliance and Market Growth with Essential Licensing Applications

Cannabis Bioscience International Holdings (OTCMKTS:CBIH) has initiated a strategic move to expand its presence in the cannabis market by filing applicati
July 08, 2024 08:00 ET | Source: CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.

CBIH Charts Path to Future Leadership in Cannabis Medicine

A letter from our desk HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Since the start of the year, Cannabis Bioscience International Holdings (OTCMKTS: CBIH) has embarked on a transformative journey...